Alchemab Therapeutics unveils Alzheimer's candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium

/PRNewswire/ -- Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today...

Related Keywords

London ,City Of ,United Kingdom ,Cambridge ,Cambridgeshire ,France ,Boston ,Massachusetts ,United States ,Sandrine Legg ,Kyoung Kwon ,Jane Osbourn , ,Antibody Industrial Symposium ,Chief Executive Officer ,Chief Scientific Officer ,Resilient Individuals ,Antibody Drug ,Phenotypic Screening ,